Please take advantage of the following educational offerings:

• For Patients with HABP/VABP: Presenting a Treatment Option Offered by Merck & Co., Inc.

The program reviews the prevalence of common bacteria involved in HABP/VABP and provides information on the clinical trial data for a treatment option and consideration. 

Multiple sessions on different dates/times are available. Click here to review available dates and to register.

• NIO & Rapid Response Webinar offered by Medline Industries, Inc.

The program discusses why, when, and how IO is in the best interest of patients when prompt peripheral access is not obtainable and reviews COVID considerations for the Rapid Response team per the CDC Recommendations.